Conclusion
On the "brain" side, shilajit stands out as a field support : mitochondrial bioenergy , redox balance , inflammatory context . Preclinical signals (CFS, tau) and human data (fatigue/recovery) converge towards an improvement in the conditions conducive to concentration and cognitive resilience - without constituting direct clinical proof on "memory" or "exam performance".
Responsible communication in Europe leads to: (i) highlighting the limits , (ii) demanding quality/COA , (iii) integrating shilajit into a lifestyle compatible with the study (sleep, light, physical activity, caffeine management). It is this nutritional & Ayurvedic positioning that we recommend.